<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05047978</url>
  </required_header>
  <id_info>
    <org_study_id>MeadJohnson</org_study_id>
    <nct_id>NCT05047978</nct_id>
  </id_info>
  <brief_title>Growth and Tolerance of a Partially Hydrolyzed Infant Formula</brief_title>
  <official_title>Growth and Tolerance of a Partially Hydrolyzed Cow's Milk Protein (PHP) Infant Formula</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mead Johnson Nutrition</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mead Johnson Nutrition</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research study is to compare the growth and tolerance of infants who&#xD;
      consume either an infant formula with intact proteins or an infant formula with partially&#xD;
      hydrolyzed proteins through approximately 12 months of age.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 28, 2021</start_date>
  <completion_date type="Anticipated">February 28, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 28, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of body weight gain</measure>
    <time_frame>up to 120 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body length</measure>
    <time_frame>up to 365 days of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Head circumference</measure>
    <time_frame>up to 365 days of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth Z scores</measure>
    <time_frame>up to 365 days of age</time_frame>
    <description>weight-for-age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth Z scores</measure>
    <time_frame>up to 365 days of age</time_frame>
    <description>length-for-age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Growth Z scores</measure>
    <time_frame>up to 365 days of age</time_frame>
    <description>head circumference-for-age</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recall of study formula intake measured at each study visit</measure>
    <time_frame>up to 365 days of age</time_frame>
    <description>questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Recall of stool characteristics measured at each study visit</measure>
    <time_frame>up to 365 days of age</time_frame>
    <description>questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pediatric Quality of Life Family Impact Module</measure>
    <time_frame>up to 365 days of age</time_frame>
    <description>questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pediatric Quality of Life Inventory Infant Scales</measure>
    <time_frame>120, 180, 275, and 365 days of age</time_frame>
    <description>Questionnaire. A 5-point response scale is utilized (0 = never a problem; 4 = always a problem). Items are reverse-scored and linearly transformed to a 0-100 scale (0 = 100, 1 = 75, 2 = 50, 3 = 25, 4 = 0), so that higher scores indicate better functioning (less negative impact).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medically confirmed adverse events collected throughout the study period</measure>
    <time_frame>up to 365 days of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specific medically confirmed adverse events related to gastrointestinal</measure>
    <time_frame>up to 365 days of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Specific medically confirmed adverse events related to allergy</measure>
    <time_frame>up to 365 days of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body weight</measure>
    <time_frame>up to 365 days of age</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Growth</condition>
  <arm_group>
    <arm_group_label>A routine cow's milk-based infant formula</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>A routine cow's milk-based infant formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>A partially hydrolyzed cow's milk protein (PHP) infant formula</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A partially hydrolyzed cow's milk protein (PHP) infant formula</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cow's milk protein infant formula</intervention_name>
    <description>A routine cow's milk-based infant formula</description>
    <arm_group_label>A routine cow's milk-based infant formula</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Partially hydrolyzed protein infant formula</intervention_name>
    <description>A partially hydrolyzed cow's milk protein (PHP) infant formula</description>
    <arm_group_label>A partially hydrolyzed cow's milk protein (PHP) infant formula</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  10 to 14 days of age at randomization&#xD;
&#xD;
          -  singleton birth&#xD;
&#xD;
          -  Gestational age of 37 to 42 weeks&#xD;
&#xD;
          -  Birth weight of 2500 g (5lbs 8oz or more)&#xD;
&#xD;
          -  Exclusively receiving infant formula for at least 24 hours prior to randomization&#xD;
&#xD;
          -  Parent or legal guardian has full intention to exclusively feed study formula through&#xD;
             120 days of age&#xD;
&#xD;
          -  Parent or legal guardian agrees not to enroll infant in another interventional&#xD;
             clinical study while participating in this study&#xD;
&#xD;
          -  Signed informed consent and authorization to use and disclose Protected Health&#xD;
             information&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of underlying metabolic or chronic disease&#xD;
&#xD;
          -  Evidence of feeding difficulties or history of formula intolerance&#xD;
&#xD;
          -  Weight at Visit 1 is &lt;98% of birth weight&#xD;
&#xD;
          -  Infant was born large for gestational age from a mother who was diabetic at childbirth&#xD;
&#xD;
          -  Infant is immunocompromised&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>14 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Wu, Medical Director</last_name>
    <role>Study Director</role>
    <affiliation>Mead Johnson Nutrition</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nakia Goodwin</last_name>
    <phone>812-429-5453</phone>
    <email>nakia.goodwin@rb.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Birmingham Pediatric Associates</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lisa Palmedo</last_name>
      <phone>205-833-2228</phone>
      <email>lisa.palmedo@actstudy.net</email>
    </contact>
    <investigator>
      <last_name>Max Hale</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southeastern Pediatric Associates</name>
      <address>
        <city>Dothan</city>
        <state>Alabama</state>
        <zip>36305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kristee Dowling</last_name>
      <phone>334-794-8656</phone>
      <email>kdowling@sepeds.com</email>
    </contact>
    <investigator>
      <last_name>Claude Ashley</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Visions Clinical Research-Tucson</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85712</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brenda Pollack</last_name>
      <phone>520-546-4700</phone>
      <email>bpollack@visionstucson.com</email>
    </contact>
    <investigator>
      <last_name>Steven Goldberg</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Northwest Arkansas Pediatric Clinic</name>
      <address>
        <city>Fayetteville</city>
        <state>Arkansas</state>
        <zip>72703</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Tiffany Matherly</last_name>
      <phone>479-571-7192</phone>
      <email>tiffany.matherly@mana.md</email>
    </contact>
    <investigator>
      <last_name>John Simmons</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Children's Clinic of Jonesboro</name>
      <address>
        <city>Jonesboro</city>
        <state>Arkansas</state>
        <zip>72401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Kim Henderson</last_name>
      <phone>870-934-3133</phone>
      <email>kimhenderson@jbrkids.com</email>
    </contact>
    <investigator>
      <last_name>Kevin Rouse</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PAS Research</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brandi Baldwin</last_name>
      <phone>813-298-9026</phone>
      <email>brandih@pas-research.com</email>
    </contact>
    <investigator>
      <last_name>Teena Hughes</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rophe Adult &amp; Pediatric Medicine</name>
      <address>
        <city>Union City</city>
        <state>Georgia</state>
        <zip>30339</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Shamekia Bennett</last_name>
      <phone>470-317-3604</phone>
      <email>sbennett@skycrng.com</email>
    </contact>
    <investigator>
      <last_name>Yvonne Smith</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Saltzer Health</name>
      <address>
        <city>Nampa</city>
        <state>Idaho</state>
        <zip>83686</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Melanie Buchanan</last_name>
      <phone>208-463-3215</phone>
      <email>mdbuchanan@saltzerhealth.com</email>
    </contact>
    <investigator>
      <last_name>Richard Aguilar</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Springs Medical Research</name>
      <address>
        <city>Owensboro</city>
        <state>Kentucky</state>
        <zip>42303</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pam Yeiser</last_name>
      <phone>270-683-3232</phone>
      <email>yeiserps@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Michael Yeiser</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Meridian Clinical Research</name>
      <address>
        <city>Grand Island</city>
        <state>Nebraska</state>
        <zip>68803</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Andrew Kimball</last_name>
      <phone>214-563-3386</phone>
      <email>akimball@mcrmed.com</email>
    </contact>
    <investigator>
      <last_name>Adam Brosz</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Jackson Clinic</name>
      <address>
        <city>Jackson</city>
        <state>Tennessee</state>
        <zip>38305</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Laura Copous</last_name>
      <phone>731-660-8320</phone>
      <email>lcopous@jacksonclinic.com</email>
    </contact>
    <investigator>
      <last_name>E. Carlton Hays</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DCOL Center for Clinical Research</name>
      <address>
        <city>Longview</city>
        <state>Texas</state>
        <zip>75605</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>April Caywood</last_name>
      <phone>903-238-8854</phone>
      <email>acaywood@dcolresearch.com</email>
    </contact>
    <investigator>
      <last_name>Michael Hudson</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>PAS Research</name>
      <address>
        <city>McAllen</city>
        <state>Texas</state>
        <zip>78501</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brandi Baldwin</last_name>
      <phone>813-330-3199</phone>
      <email>brandih@pas-research.com</email>
    </contact>
    <investigator>
      <last_name>Ashley Bose</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 8, 2021</study_first_submitted>
  <study_first_submitted_qc>September 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 17, 2021</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caseins</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

